Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Indiana 25 trials found
New Search
Filter
Trial Phase
Study Type
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
N/AOBSERVATIONAL Indianapolis, Indiana
RECRUITING
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
PHASE2INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
PHASE3INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Galleri® in the Medicare Population.
NAINTERVENTIONAL Fort Smith, Arkansas +4 more
RECRUITING
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
PHASE2, PHASE3INTERVENTIONAL Vallejo, California +4 more
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
PHASE2INTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
PHASE2INTERVENTIONAL Indianapolis, Indiana +3 more
RECRUITING
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
N/AOBSERVATIONAL Santa Monica, California +4 more
RECRUITING
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NAINTERVENTIONAL Carmel, Indiana +2 more
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
N/AOBSERVATIONAL Indianapolis, Indiana +2 more
RECRUITING
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
PHASE2INTERVENTIONAL Indianapolis, Indiana +3 more
RECRUITING
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
PHASE2, PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type